3D Medical (ASX:3DM) has signed a letter of intent with Telstra (ASX:TLS) as part of Telstra Health’s development of an Image and Data Management Service.
The company has secured exclusive reseller rights in Australia and New Zealand to Mach7 Technologies, a leading developer of image management solutions for hospitals, radiology clinics and other health service providers.
Mach 7’s vendor neutral Enterprise Imaging Platform is designed to enable ownership, sharing and access of imaging data to improve patient care, revenues, compliance and clinician satisfaction across the enterprise.
The Letter of Intent will allow the parties to explore entering a commercial relationship following joint testing and evaluation of the Mach7 enterprise imaging solution.
The Software Licence and Support Agreement will enable supply of Telstra’s IDMS to 3DM customers and allow both organisations to offer the service to a new customer base. Commercial release is planned for Q1FY16.
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.
Add to My Watchlist
What is My Watchlist?